This cluster is entirely director-level selling with no C-suite participation, totaling just 0.011% of market cap — well below any materiality threshold. The sales are likely liquidity-driven following derivative exercises. No actionable signal for traders; ignore this cluster.
Price Chart
Executive Summary
Two directors at ImmunityBio sold a combined ~$1.06M in open-market sales over a 7-day window, with the largest sale ($862K) occurring on June 29 at ~$9.01. The cluster is 100% selling by non-C-suite directors, with total value representing ~0.01% of the $9.6B market cap — well below the 0.1% materiality threshold. The sales are trivial relative to company size and carry no informational signal per the academic literature on director-level sales.
Key Financial Metrics
Key Facts
- Two directors sold a combined ~$1.06M in open-market sales over a 7-day window ending June 29, 2026
- Total sales represent ~0.011% of IBRX's $9.6B market cap — well below the 0.1% materiality threshold
- No C-suite executives (CEO, CFO, COO) participated in any trades — only directors
- Director Selecky Christobel's sales ($871K) were preceded by derivative exercises at $2.98 strike, suggesting tax/vesting-related liquidity rather than a bearish view
- Director Simon Barry J. sold $197K at $7.88 — a trivial amount for a $9.6B company
- Historical performance on IBRX reports shows a -7.29% average T+20 return and 50% win rate, with one severe -36% miss on a score-6 long call — caution warranted on bullish reads
Financial Impact
Total insider sales of ~$1.06M represent ~0.011% of IBRX's $9.6B market cap — trivial and routine
Risk Factors
- Historical IBRX reports show poor T+20 performance (-7.29% avg return, 50% win rate) — prior bullish calls on this ticker have underperformed
- No C-suite participation in this cluster — director-level sales carry minimal informational content
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-IBRX-1782976386047 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 4, 2026 8w ago | 8-K | $6.95 $7.87 | ▲ +13.24% | ▲ +14.48% | $10.28 (+47.99%) |
Jul 6, 2026 12w ago | Insider Cluster | $8.91 $7.17 | ▼ −19.53% | ▼ −18.96% | $10.28 (+15.43%) |
Jul 1, 2026 13w ago | Insider Cluster | $9.20 $6.83 | ▼ −25.76% | ▼ −23.58% | $10.28 (+11.79%) |
May 18, 2026 19w ago | 8-K | $7.76 $6.99 | ▼ −9.92% | ▼ −10.91% | $10.28 (+32.54%) |
Apr 9, 2026 25w ago | 8-K | $7.48 $8.38 | ▲ +12.03% | ▲ +4.46% | $10.28 (+37.50%) |
Apr 6, 2026 25w ago | 8-K | $7.08 $7.43 | ▲ +4.94% | ▼ −4.04% | $10.28 (+45.27%) |
Feb 28, 2026 30w ago | Institutional Cluster | $10.44 $6.66 | ▼ −36.21% | ▼ −28.27% | $10.28 (−1.48%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access